For retatrutide: trials are underway along the same lines The TRIUMPH program includes equivalent pleiotropic trials for retatrutide: a sleep apnea arm (TRIUMPH-OSA), a MASLD arm (TRIUMPH-MASLD), and a cardiovascular trial (CVOT)
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment
A meaningful antioxidant has two characteristics (these are based on the assumption that the compound is an antioxidant): Found in appreciable amounts right location where there are free radicals/ROS that need to be quenched It is not redundant with another antioxidant that is already serving as an antioxidant What do these mean
Jianping W, Xuelian Z, Anjiang W, Haiying X
This receptor modulation triggers a cascade of intracellular signaling events that ultimately result in the activation of hormone-sensitive lipase, the enzyme responsible for breaking down stored triglycerides into free fatty acids and glycerol
Tirzepatides longer-term outcomes data is still accumulating
